1710MO Belzutifan for advanced pancreatic neuroendocrine tumors (panNETs): Results from cohort A2 of the phase II LITESPARK-015 study. - Capdevila, J.; Artamonova, E.; de Jesus Acosta, A.; Niccoli, P.; Toth, M.; Ramirez, R.A.; Hendifar, A.; Cingarlini, S.; Trikalinos, N.; Quante, M.; Garcia-Carbonero, R.; Goker, E.; et al. (Annals of Oncology, 2025)